Activators identified for the treatment of patients with diabetes and insulin resistance
La Vanguardia, La Razón, Correo Farmacéutico, Health Canal, among other national and international media, have published an article about the research led by Antonio Zorzano, from IRB Barcelona, and Fernando Albericio, from the University of Barcelona. This study reveals activators of mitochondrial protein Mitofusin 2 that may be valuable in the treatment of type 2 diabetes.
Link to La Vanguardia
Link to Correo Farmacéutico
Link to Health Canal
Related content
News
The Academia Programme run by ICREA seeks to foster research excellence among professors at public universities in Catalonia.
2020 got off to a flying start for Jessica Vitos with the publication of a paper in PNAS addressing how cancer cells exploit the p38 protein to further their growth and division. Jessica, who did her PhD under the supervision of Ángel Nebreda, defended her thesis back in January 2018 and a year later moved away from the bench to join Ysios, a venture capital company.
The team headed by ICREA researcher, Lluís Ribas, has published a study in Cell Report describing a functional network that coordinates protein synthesis and DNA replication in animal mitochondria.
These findings contribute to our understanding of the mechanisms involved in mitochondrial dysregulation associated with diseases such as MELAS and MERRF and may help to identify new therapeutic approaches.
